These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24313465)

  • 1. Dynamic interplay between autophagic flux and Akt during melanoma progression in vitro.
    Maes H; Martin S; Verfaillie T; Agostinis P
    Exp Dermatol; 2014 Feb; 23(2):101-6. PubMed ID: 24313465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH; Bohula EA; Macaulay VM
    Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes.
    Larribere L; Khaled M; Tartare-Deckert S; Busca R; Luciano F; Bille K; Valony G; Eychene A; Auberger P; Ortonne JP; Ballotti R; Bertolotto C
    Cell Death Differ; 2004 Oct; 11(10):1084-91. PubMed ID: 15243584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of (V600E)BRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism.
    Sánchez-Hernández I; Baquero P; Calleros L; Chiloeches A
    Cancer Lett; 2012 Jan; 314(2):244-55. PubMed ID: 22056813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
    Ogawa K; Sun C; Horii A
    Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma.
    Corazzari M; Rapino F; Ciccosanti F; Giglio P; Antonioli M; Conti B; Fimia GM; Lovat PE; Piacentini M
    Cell Death Differ; 2015 Jun; 22(6):946-58. PubMed ID: 25361077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.
    Marsh Durban V; Deuker MM; Bosenberg MW; Phillips W; McMahon M
    J Clin Invest; 2013 Dec; 123(12):5104-18. PubMed ID: 24200692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C; Marais R
    J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein kinase 1α-dependent feedback loop controls autophagy in RAS-driven cancers.
    Cheong JK; Zhang F; Chua PJ; Bay BH; Thorburn A; Virshup DM
    J Clin Invest; 2015 Apr; 125(4):1401-18. PubMed ID: 25798617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
    Gambichler T; Harnischfeger F; Skrygan M; Majchrzak-Stiller B; Buchholz M; Müller T; Braumann C
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment.
    Meier F; Busch S; Lasithiotakis K; Kulms D; Garbe C; Maczey E; Herlyn M; Schittek B
    Br J Dermatol; 2007 Jun; 156(6):1204-13. PubMed ID: 17388918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.
    Boisvert-Adamo K; Aplin AE
    Oncogene; 2006 Aug; 25(35):4848-56. PubMed ID: 16547495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.
    Dumaz N; Hayward R; Martin J; Ogilvie L; Hedley D; Curtin JA; Bastian BC; Springer C; Marais R
    Cancer Res; 2006 Oct; 66(19):9483-91. PubMed ID: 17018604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
    Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
    Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the PI3K-AKT pathway in melanoma.
    Davies MA
    Cancer J; 2012; 18(2):142-7. PubMed ID: 22453015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting NRAS in melanoma.
    Kelleher FC; McArthur GA
    Cancer J; 2012; 18(2):132-6. PubMed ID: 22453013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152.
    Kim YK; Ahn SK; Lee M
    Cancer Lett; 2012 Jul; 320(2):215-24. PubMed ID: 22425959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt induces apoptosis in neuroblastoma cells expressing a C98X vasopressin mutant following autophagy suppression.
    Castino R; Thepparit C; Bellio N; Murphy D; Isidoro C
    J Neuroendocrinol; 2008 Oct; 20(10):1165-75. PubMed ID: 18673414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.